• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,2,3-三唑查尔酮杂合体的合成、体外细胞毒性活性及对多发性骨髓瘤 RPMI-8226 细胞凋亡诱导的机制研究。

1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226.

机构信息

Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University, New Dammeitta, Egypt.

Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Delta University, Gamsaa, Egypt.

出版信息

Eur J Med Chem. 2020 Mar 1;189:112062. doi: 10.1016/j.ejmech.2020.112062. Epub 2020 Jan 17.

DOI:10.1016/j.ejmech.2020.112062
PMID:31986406
Abstract

A new series of 1,2,3-triazole-chalcone hybrids has been synthesized and screened in vitro against a panel of 60 human cancer cell lines according to NCI (USA) protocol. Compound 4d having 3, 4-dimethoxyphenyl chalcone moiety, the most potent derivative, inhibited the growth of RPMI-8226 and SR leukemia cell lines by 99.73% and 94.95% at 10 μM, respectively. Also, it inhibited the growth of M14 melanoma, K-562 leukemia, and MCF7 breast cancer cell lines by more than 80% at the same test concentration. 4d showed IC values less than 1 μM on six types of tumor cells and high selectivity index reached to 104 fold on MCF7. Compound 4d showed superior activity than methotrexate and gefitinib against the most sensitive leukemia cell lines in addition to higher or comparable activity against the rest sensitive cell lines. Flow cytometry analysis in RPMI-8226 cells revealed that compound 4d caused cell cycle arrest at G2/M phase and induced apoptosis in a dose dependant manner. Mechanistic evaluation referred this apoptosis induction to triggering mitochondrial apoptotic pathway through inducing ROS accumulation, increasing Bax/Bcl-2 ratio and activation of caspases 3, 7 and 9.

摘要

已合成了一系列新的 1,2,3-三唑查耳酮杂合体,并根据美国国家癌症研究所(NCI)的方案在体外对 60 个人类癌细胞系进行了筛选。具有 3,4-二甲氧基苯基查耳酮部分的化合物 4d 是最有效的衍生物,在 10 μM 时分别抑制 RPMI-8226 和 SR 白血病细胞系的生长达 99.73%和 94.95%。此外,它在相同的测试浓度下抑制 M14 黑色素瘤、K-562 白血病和 MCF7 乳腺癌细胞系的生长超过 80%。4d 在六种肿瘤细胞上的 IC 值小于 1 μM,对 MCF7 的选择性指数高达 104 倍。与甲氨蝶呤和吉非替尼相比,化合物 4d 对最敏感的白血病细胞系具有更高的活性,并且对其余敏感细胞系的活性也更高或相当。在 RPMI-8226 细胞中的流式细胞术分析表明,化合物 4d 以剂量依赖的方式导致细胞周期停滞在 G2/M 期并诱导细胞凋亡。机制评估表明,这种细胞凋亡的诱导是通过触发线粒体凋亡途径,通过诱导 ROS 积累、增加 Bax/Bcl-2 比值和激活 caspase 3、7 和 9 来实现的。

相似文献

1
1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226.1,2,3-三唑查尔酮杂合体的合成、体外细胞毒性活性及对多发性骨髓瘤 RPMI-8226 细胞凋亡诱导的机制研究。
Eur J Med Chem. 2020 Mar 1;189:112062. doi: 10.1016/j.ejmech.2020.112062. Epub 2020 Jan 17.
2
New 1,2,4-triazole-Chalcone hybrids induce Caspase-3 dependent apoptosis in A549 human lung adenocarcinoma cells.新型 1,2,4-三唑查尔酮杂合体诱导 A549 人肺腺癌细胞 Caspase-3 依赖性细胞凋亡。
Eur J Med Chem. 2018 May 10;151:705-722. doi: 10.1016/j.ejmech.2018.03.073. Epub 2018 Mar 27.
3
Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway.设计、合成及 2'-羟基-4'-烷氧基查耳酮衍生物的定量构效关系研究,此类衍生物通过线粒体凋亡途径发挥细胞毒性活性。
Bioorg Med Chem. 2019 Jan 1;27(1):43-54. doi: 10.1016/j.bmc.2018.10.045. Epub 2018 Nov 10.
4
Discovery of novel steroidal-chalcone hybrids with potent and selective activity against triple-negative breast cancer.发现具有高效和选择性活性的新型甾体-查尔酮杂合体,针对三阴性乳腺癌。
Bioorg Med Chem. 2020 Dec 1;28(23):115763. doi: 10.1016/j.bmc.2020.115763. Epub 2020 Sep 12.
5
Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I/II inhibitory activities and caspases-mediated apoptosis.新型脲连接的环丙沙星-查尔酮杂合体具有抗增殖拓扑异构酶 I/II 抑制活性和半胱天冬酶介导的细胞凋亡。
Bioorg Chem. 2021 Jan;106:104422. doi: 10.1016/j.bioorg.2020.104422. Epub 2020 Oct 22.
6
Quinazoline-chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in-silico studies of potential anticancer activity against multiple myeloma.喹唑啉-查尔酮杂合体作为 HDAC/EGFR 双重抑制剂:对多发性骨髓瘤潜在抗癌活性的设计、合成、机制和计算机研究。
Arch Pharm (Weinheim). 2024 May;357(5):e2300626. doi: 10.1002/ardp.202300626. Epub 2024 Jan 31.
7
Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1,2,3-triazole-chalcone conjugates.新型合成的1,2,3-三唑-查耳酮缀合物处理白血病癌细胞后的凋亡诱导、PARP-1抑制及细胞周期分析
Bioorg Chem. 2022 Jun;123:105762. doi: 10.1016/j.bioorg.2022.105762. Epub 2022 Mar 26.
8
Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.新型苯并三唑 N-酰基芳腙杂合体的设计、合成及抗癌活性、对细胞周期谱的影响、caspase-3 介导的细胞凋亡和 FAK 抑制作用。
Bioorg Chem. 2018 Oct;80:531-544. doi: 10.1016/j.bioorg.2018.07.008. Epub 2018 Jul 10.
9
Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.通过分子杂交方法获得的 1-(3',4',5'-三甲氧基苯基)-3-(2'-烷氧基羰基吲哚基)-2-丙烯-1-酮衍生物的设计、合成、体外增殖活性和诱导凋亡研究。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1225-1238. doi: 10.1080/14756366.2018.1493473.
10
Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis, F-radiolabeling & galectin-1 inhibition studies.新型苯并咪唑-三唑杂合体作为肺癌凋亡诱导剂的研究:设计、合成、F-放射性标记及半乳糖凝集素-1 抑制研究。
Bioorg Chem. 2020 Sep;102:104125. doi: 10.1016/j.bioorg.2020.104125. Epub 2020 Jul 22.

引用本文的文献

1
Synthesis, characterization, anti-proliferative, and apoptotic activity of a novel quinazoline-containing 1,2,3-triazole toward three human cancer cells.一种新型含喹唑啉的1,2,3-三唑对三种人类癌细胞的合成、表征、抗增殖及凋亡活性
Sci Rep. 2025 Jul 1;15(1):20852. doi: 10.1038/s41598-025-05270-z.
2
Synthesis and evaluation of quinolinvinyl-phenoxy-1,2,3-triazole-acetamide hybrids against breast cancer.喹啉乙烯基-苯氧基-1,2,3-三唑-乙酰胺杂化物对乳腺癌的合成与评价
Sci Rep. 2025 May 16;15(1):17058. doi: 10.1038/s41598-025-01051-w.
3
Therapeutic potential of chalcone-1,2,3-triazole hybrids as anti-tumour agents: a systematic review and SAR studies.
查尔酮-1,2,3-三唑杂化物作为抗肿瘤药物的治疗潜力:系统评价与构效关系研究
Future Med Chem. 2025 Feb;17(4):449-465. doi: 10.1080/17568919.2025.2458450. Epub 2025 Jan 31.
4
Potent EGFR/PARP-1 inhibition by spirooxindole-triazole hybrids for targeted liver cancer therapy.螺环氧化吲哚-三唑杂化物对表皮生长因子受体/聚(ADP-核糖)聚合酶-1的强效抑制作用用于靶向肝癌治疗。
RSC Adv. 2025 Jan 3;15(1):58-74. doi: 10.1039/d4ra05966b. eCollection 2025 Jan 2.
5
Novel Bis-1,2,3-triazole-thiazolidinone hybrid as anticancer agents that induce apoptosis and molecular modeling study.新型双-1,2,3-三唑-噻唑烷酮杂化物作为诱导细胞凋亡的抗癌剂及分子模拟研究
Future Med Chem. 2024;16(21):2193-2210. doi: 10.1080/17568919.2024.2394019. Epub 2024 Oct 10.
6
Design, synthesis and in silico molecular docking evaluation of novel 1,2,3-triazole derivatives as potent antimicrobial agents.新型1,2,3-三唑衍生物作为强效抗菌剂的设计、合成及计算机辅助分子对接评估
Heliyon. 2024 Mar 24;10(7):e27773. doi: 10.1016/j.heliyon.2024.e27773. eCollection 2024 Apr 15.
7
Synthesis and biological evaluation of ciprofloxacin - 1,2,3-triazole hybrids as antitumor, antibacterial, and antioxidant agents.环丙沙星-1,2,3-三唑杂化物作为抗肿瘤、抗菌和抗氧化剂的合成及生物学评价
Heliyon. 2023 Nov 28;9(12):e22592. doi: 10.1016/j.heliyon.2023.e22592. eCollection 2023 Dec.
8
Design, synthesis, and unraveling the antibacterial and antibiofilm potential of 2-azidobenzothiazoles: insights from a comprehensive study.2-叠氮基苯并噻唑的设计、合成及其抗菌和抗生物膜潜力解析:一项综合研究的见解
Front Chem. 2023 Sep 7;11:1264747. doi: 10.3389/fchem.2023.1264747. eCollection 2023.
9
Recent Advances in the Green Synthesis of Active -Heterocycles and Their Biological Activities.活性杂环化合物的绿色合成及其生物活性的最新进展
Pharmaceuticals (Basel). 2023 Jun 13;16(6):873. doi: 10.3390/ph16060873.
10
Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents inhibition of PI3K/Akt/mTOR signalling pathway.新型1,2,3-三唑查尔酮衍生物作为潜在抗骨肉瘤药物的设计与开发:对PI3K/Akt/mTOR信号通路的抑制作用
Acta Pharm. 2022 Apr 13;72(3):389-402. doi: 10.2478/acph-2022-0026. Print 2022 Sep 1.